ArticleInternational journal of cancer2016

Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status.

Junko Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.